Efficient CRISPR Cas13 in The Treatment of The COVID-19

Manli Jian

doi:10.62051/ckdpc470

Authors

Manli Jian

DOI:

https://doi.org/10.62051/ckdpc470

Keywords:

CRISPR Cas13; COVID-19; RNA-targeting.

Abstract

Currently, CRISPR Cas13 is one of the rapid advancement and growing potential in the fields of diagnostics and therapeutics. It has proven highly effective in detecting RNA viruses like SARS-CoV-2, making it an essential tool for identifying COVID-19 variants. However, since CRISPR Cas13 is a newly emerged technology in the CRISPR system, there are still some problems that need to be tackled. This article aims to discuss the application of CRISPR Cas13 in treating COVID 19. Two CRISPR Cas13 based diagnostic tools, PAC-MAN and CARMEN, hold potential for detecting variants, with research indicating their ability to degrade viral RNA and suppress viral gene expression. Despite this potential, challenges remain, particularly in achieving efficient and safe delivery systems for Cas13. While it is not yet fully implemented in clinical settings, the progress made so far highlights CRISPR Cas13’s significant role in addressing viral outbreaks, specifically COVID 19 and its potential for future applications in infectious diseases and other RNA-based conditions.

Downloads

Download data is not yet available.

References

[1] What is CRISPR? The Jackson Laboratory. Available at: https://www.jax.org/personalized-medicine/precision-medicine-and-you/what-is-crispr.

[2] Balska AK, Krawczyk A. Mechanism of the CRISPR-Cas13 (Type VI) System. RNA-Targeting CRISPR–Cas Systems and Their Applications, 2022-02. Available at: www.researchgate.net/figure/Mechanism-of-the-CRISPR-Cas13-type-VI-system-The-CRISPR-array-is-transcribed-into-a_fig2_339121330.

[3] Coronavirus. World Health Organization. Available at: https://www.who.int/health-topics/coronavirus.

[4] Singh SJ, et al. Respiratory sequelae of COVID-19: pulmonary and extrapulmonary origins, and approaches to clinical care and rehabilitation. Lancet Respiratory Medicine, 2023.

[5] SARS-CoV-2 and COVID-19. Baylor College of Medicine. Available at: https://www.bcm.edu/departments/molecular-virology-and-microbiology/emerging-infections-and-biodefense/specific-agents/sars-cov-2-and-covid-19.

[6] Zhou Q, et al. Advances of CRISPR-Cas13 system in COVID-19 diagnosis and treatment. Genes & Diseases, 2022, 10: 2414–2424.

[7] Tang WF, Tran AT, Wang LY, Horng JT. SARS-CoV-2 pandemics: An update of CRISPR in diagnosis and host–virus interaction studies. Biomedical Journal, 2023, 46: 100587.

[8] Rajan A, et al. CRISPR-Cas System: From Diagnostic Tool to Potential Antiviral Treatment. CRISPR Antiviral System: Topics by Science.Gov, 2022-08. Available at: www.science.gov/topicpages/c/crispr+antiviral+system.html.

[9] Abbott TR, et al. Development of CRISPR as an Antiviral Strategy to Combat SARS-CoV-2 and Influenza. Cell, 2020, 181: 865-876.e12.

[10] Cheng X, et al. Modeling CRISPR-Cas13d on-target and off-target effects using machine learning approaches. Nature Communications, 2023, 14: 752.